Exone leading, followed by Excombi, and Baldifin … Expogi still strong
(Medipana)
Since last Octover, among generics of Novartis ‘Exposi’ CJ, Daewon, and Kyungdong are top 3 players revealed.
According to Ubist date on November 20, incrementally modified drugs and generics have been competed after Exposi patent expired.
Those succeeding drugs had been prescribed total 2 billion won in O...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.